Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
99
days
HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
Authors
Ryohei Ono; Kieran F. Docherty; Alasdair D. Henderson; Brian L. Claggett; Akshay S. Desai; Carolyn S.P. Lam; Michele Senni; Sanjiv J. Shah; Morten Schou; Adriaan A. Voors; Flaviana Amarante; James Lay-Flurrie; Andrea Glasauer; Faiez Zannad; Muthiah Vaduganathan; Pardeep S. Jhund; Scott D. Solomon; John J.V. McMurrayShow moreShow less
Affiliations
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; National Heart Centre Singapore & Duke-National University of Singapore, Singapore; University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark; University of Groningen, Groningen, the Netherlands; Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil; Bayer PLC, Research & Development, Pharmaceuticals, Reading, United Kingdom; Bayer AG, Global Medical Affairs, Berlin, Germany; Université de Lorraine, Inserm Clinical Investigation Centre, CHU, Nancy, FranceShow moreShow less
122
days
The Yield of Clinical Screening in Pediatric Relatives of Hypertrophic Cardiomyopathy With Negative Genetic Testing
Authors
Gabrielle Norrish; Emma Pascall; Ella Field; Stephanie Oates; Elena Cervi; Juan Pablo KaskiShow moreShow less
Affiliations
Great Ormond Street Hospital Centre for Inherited Cardiovascular Diseases, London, United Kingdom; UCL Centre for Paediatric Inherited and Rare Cardiovascular Disease, London, United KingdomShow moreShow less
55
days
National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction
Authors
Mohammad Keykhaei; Alexander T. Sandhu; Priscilla Y. Hsue; Stephen J. Greene; Boback Ziaeian; Michelle Kittleson; MaryAnn Villarreal-Gonzalez; Shahin Hallaj; Mattheus Ramsis; Manyoo A. Agarwal; Gregg C. FonarowShow moreShow less
Affiliations
Division of Cardiology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Medicine, University of California–San Diego, San Diego, California, USA; Division of Cardiology, Department of Medicine, University of California–San Diego, San Diego, California, USA; Division of Biomedical Informatics, Department of Medicine, University of California–San Diego, San Diego, California, USA; Division of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAEShow moreShow less
196
days
The MagMa Study
Authors
Phillip Suwalski; Finn Wilke; Ekaterina Latinova; Gabriele Paci; Gamze Satilmis; Karin Klingel; Sebastian Kelle; January Weiner; Dieter Beule; Thomas F. Lüscher; Ulf Landmesser; Bettina HeideckerShow moreShow less
Affiliations
German Heart Center of Charité, Charité–University Medicine Berlin, Berlin, Germany; Department of Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany; Berlin Institute of Health, Charité–University Medicine Berlin, Berlin, Germany; Heart Division, Royal Brompton Hospital, King’s College and Imperial College London, London, United Kingdom; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland; German Center for Cardiovascular Research, Berlin, GermanyShow moreShow less
77
days
NOTIFY-HF
Authors
Joseph Assad; Nancy E. Briggs; Sidney Lo; Rohan Rajaratnam; Giuseppe Femia; Dominic Leung; Hany DimitriShow moreShow less
Affiliations
Department of Cardiology, Liverpool Hospital, South Western Sydney Local Health District, Sydney, New South Wales, Australia; South West Clinical School, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia; Ingham Institute of Applied Medical Research, Liverpool, New South Wales, Australia; Mark Wainwright Analytical Centre, University of New South Wales, Sydney, New South Wales, Australia; Western Sydney University, School of Medicine, Sydney, New South Wales, Australia; The University of Sydney, School of Medicine, Camperdown, New South Wales, AustraliaShow moreShow less
192
days
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients
Authors
Mehmet K. Aktaş; Khawaja M. Talha; Ilan Goldenberg; Wojciech Zareba; Michael Böhm; Amr Abdin; Martina Brueckmann; Cordula Zeller; Liliana Zaremba-Pechmann; Stuart Pocock; Faiez Zannad; Stefan D. Anker; Gerasimos Filippatos; Javed Butler; João Pedro Ferreira; Milton PackerShow moreShow less
Affiliations
Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA; Department of Cardiovascular Disease, Loyola University Medical Center, Maywood, Illinois, USA; Departments of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University, Saarbrücken, Germany; Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany; Elderbrook Solutions, Krakow, Poland; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre d’Investigations Cliniques Plurithématique 1433, Université de Lorraine, Institut National de la Santé et de la Recherche Médicale 1116, Centre Hospitalier Régional Universitaire de Nancy, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Nancy, France; Department of Cardiology (CVK) of German Heart Center Charité, German Centre for Cardiovascular Research (DZHK), Charité Universitätsmedizin, Berlin, Germany; National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA; Baylor Scott and White Research Institute, Dallas, Texas, USA; Cardiovascular R&D Center, Faculty of Medicine, University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Hospital de Gaia/Espinho, Gaia, Portugal; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USAShow moreShow less
FAQ
How long does JACC-Heart Failure take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for JACC-Heart Failure. The fastest paper went from submission to acceptance in 54 days (Psychiatric Disorders and Mortality in Heart Failure, received 2026-02-12, accepted 2026-04-07); the slowest took 349 days. The average is 130.6 days and the median is 107.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
